C. Ettorre

Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study

Alberto Tosetto, Zahra Badiee, Mohammad‐Reza Baghaipour et al. · Journal of Thrombosis and Haemostasis · 2020 · 35 citations · Full text

Medicine, Hematology, Pathology +14

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

Nicoletta Riva, Walter Ageno, Daniela Poli et al. · Journal of Thrombosis and Haemostasis · 2015 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Effectiveness of Defibrotide for Prophylaxis of Deep Venous Thrombosis in Gynecological Surgery: A Double-Blind, Placebo-Controlled Clinical Trial

N. Ciavarella, C. Ettorre, M. Schiavoni et al. · Haemostasis · 2009 · 14 citations

Medicine, Pharmacotherapy, Surgery +17

Assessment of the Olfactory Function in Italian Patients with Type 3 von Willebrand Disease Caused by a Homozygous 253 Kb Deletion Involving VWF and TMEM16B/ANO2

Valentina Cenedese, Massimo Mezzavilla, Anna Morgan et al. · PLoS ONE · 2015 · 13 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

<p>Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A</p>

Giovanni Di Minno, Elena Santagostino, Massimo Morfini et al. · Patient Preference and Adherence · 2019 · 13 citations · Full text

Medicine, Hematology, Pharmacotherapy +15